See also this year's filing and all EDGAR filings for this company.
PDF Report 0001636651_2023_Ovid_Therapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001636651, Ovid Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 131,380,691 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,147,963 |
| 3 | remainder_Assets | 22,737,160 |
| 4 | LiabilitiesCurrent | 6,991,525 |
| 5 | LiabilitiesNoncurrent | 16,001,725 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 32,432,510 |
| 9 | ResearchAndDevelopmentExpense | 24,618,399 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,502,748 |
| 12 | remainder_NetIncome | 1,379,132 |
| 13 | remainder_ComprehensiveNetIncome | -42,187 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 155,265,814 |
| 1 | Liabilities | 22,993,250 |
| 2 | Expenses | 57,050,909 |
| 3 | Revenues | 1,502,748 |
| 4 | StockholdersEquity | 132,272,564 |
| 5 | NetIncome | -54,169,029 |
| 6 | ComprehensiveNetIncome | -54,190,122 |
| 7 | BaseVar | 119,117,020 |
| 8 | EconomicCapitalRatio | 1.94 |
Edgar->Model Mapping
Feature Distribution
Change over Time
